The approval was based on data from a clinical program that included 23 clinical trials enrolling more than 5000 adults with type 2 diabetes mellitus.
Nirsevimab is a long-acting anti-RSV for nirsevimab for the prevention of RSV lower.
Actemra (tocilizumab) is an interleukin-6 receptor antagonist.
Pataday Once Daily Relief Extra Strength is indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander.
Refresh Digital is designed to protect tears from evaporating due to incomplete blinking during digital device use.
The investigational nasal spray contains varenicline, a highly selective nicotinic acetylcholine agonist.
Brinzolamide ophthalmic suspension 1% is indicated for elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
The over-the-counter product may be used as a protectant against further eye irritation and to relieve dryness of the eye.
The approval was based on data from two randomized, multicenter, double-masked, vehicle-controlled trials that evaluated the efficacy and safety of Verkazia in patients with VKC.
ALK-001 is an oral, once daily, chemically-modified form of vitamin A.
The FDA has granted Orphan Drug designation to ADX-2191 (methotrexate for intravitreal injection) for the treatment of retinitis pigmentosa.
Difluprednate Ophthalmic Emulsion 0.05% is an AB-rated generic equivalent of Durezol.
The application is supported by data from the phase 2 IMCgp100-202 trial that assessed tebentafusp in 378 HLA-A*02:01-positive adults with previously untreated metastatic uveal melanoma.
